Strategic Collaboration Opportunity to partner with Arnav Biotech on a purification and analytical platform for mRNA pipelines, signaling a potential joint offering or OEM collaboration to expand into mRNA therapeutics and vaccines.

AAV and Gene Therapy Strong focus on viral vectors and gene therapy purification (AAV, adenovirus, lentivirus) suggests potential sales opportunities with biotechs and CROs developing gene therapies needing high-speed, high-capacity downstream purification solutions.

Monolithic Advantage CIM Monolithic Columns enable high flow rates and scalable purifications, presenting value to companies seeking cost-effective, scalable purification for large biomolecules and complex batches like mAbs, IVIG, and PEGylated proteins.

Global Expansion Recent facility expansion and international footprint indicate capacity to support regional deployments, service, and training, enabling faster onboarding of new customers and regional support for multi-site manufacturing.

Strategic Growth Signals Part of Sartorius group with ongoing partnerships and investments, plus historical collaborations with Biomay and ongoing Cornerstone AAV services, pointing to strong credibility and cross-sell opportunities within a broader life-science ecosystem.